MX2018001576A - Piridinas y su uso en el tratamiento del cancer. - Google Patents
Piridinas y su uso en el tratamiento del cancer.Info
- Publication number
- MX2018001576A MX2018001576A MX2018001576A MX2018001576A MX2018001576A MX 2018001576 A MX2018001576 A MX 2018001576A MX 2018001576 A MX2018001576 A MX 2018001576A MX 2018001576 A MX2018001576 A MX 2018001576A MX 2018001576 A MX2018001576 A MX 2018001576A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- pyridines
- cancer
- compounds
- cancers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporcionan compuestos de la Fórmula (I)(ver formula) (I) o sales de aquellos aceptables desde el punto de vista farmacéutico, en donde L, R1, R2, R3, R4 y n tienen significados proporcionados en la descripción, en donde los compuestos son útiles en el tratamiento de tipos de cáncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1514021.3A GB201514021D0 (en) | 2015-08-07 | 2015-08-07 | Novel Pyridines and their use in the treatment of cancer |
PCT/US2016/045731 WO2017027359A1 (en) | 2015-08-07 | 2016-08-05 | Pyridines and their use in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018001576A true MX2018001576A (es) | 2018-11-09 |
Family
ID=54200423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018001576A MX2018001576A (es) | 2015-08-07 | 2016-08-05 | Piridinas y su uso en el tratamiento del cancer. |
Country Status (12)
Country | Link |
---|---|
US (1) | US10899710B2 (es) |
EP (1) | EP3331858A1 (es) |
JP (1) | JP6636153B2 (es) |
KR (1) | KR102180934B1 (es) |
CN (1) | CN108026044A (es) |
AU (1) | AU2016306276B2 (es) |
CA (1) | CA2995077C (es) |
GB (1) | GB201514021D0 (es) |
MA (1) | MA42915A (es) |
MX (1) | MX2018001576A (es) |
RU (1) | RU2730505C2 (es) |
WO (1) | WO2017027359A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201514021D0 (en) | 2015-08-07 | 2015-09-23 | Arner Elias Set Jeno | Novel Pyridines and their use in the treatment of cancer |
CR20180596A (es) * | 2016-05-24 | 2019-04-09 | Basf Se | Uracilpiridinas herbicidas |
KR20190115012A (ko) | 2017-02-07 | 2019-10-10 | 오블리크 세러퓨틱스 에이비 | 헤테로사이클릴설포닐-치환된 피리딘 및 암의 치료에서 이의 용도 |
CA3051644A1 (en) | 2017-02-07 | 2018-08-16 | Oblique Therapeutics Ab | Sulfinylpyridines and their use in the treatment of cancer |
BR112019016223A2 (pt) | 2017-02-07 | 2020-04-07 | Oblique Therapeutics Ab | piridinas substituídas por heteroarilsulfonila e uso das mesmas no tratamento de câncer |
CN110382464A (zh) | 2017-02-07 | 2019-10-25 | 欧比力克治疗公司 | 烃基磺酰基取代的吡啶和其在癌症治疗中的用途 |
CA3091085A1 (en) * | 2018-02-12 | 2019-08-15 | Cinda Pharma Ab | Thioredoxin reductase inhibitors for use in the treatment of cancer |
EP3959199A4 (en) * | 2019-04-24 | 2023-06-28 | Memorial Sloan Kettering Cancer Center | Compositions and methods for treating ras-mutant cancers |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3064846D1 (en) | 1979-12-19 | 1983-10-20 | Duphar Int Res | New nitrothiophenes, method of preparing the new compounds, as well as fungicidal and/or bactericidal compositions on the basis of the new compounds |
AU543161B2 (en) | 1980-03-07 | 1985-04-04 | E.I. Du Pont De Nemours And Company | Pyrimidine or s.triazine derivatives |
US4456469A (en) | 1980-03-07 | 1984-06-26 | E. I. Du Pont De Nemours And Company | Pyridyl sulfone herbicides |
US4791127A (en) | 1985-10-07 | 1988-12-13 | Nippon Kayaku Kabushiki Kaisha | Alkanesulfonate derivatives and their use as insecticides, acaricides or nematicides |
DE3812177A1 (de) | 1988-04-13 | 1989-10-26 | Bayer Ag | 2-phenylsulfinyl-nitro-pyridine, verfahren zu ihrer herstellung und ihre verwendung |
AU2395095A (en) | 1994-04-29 | 1995-11-29 | G.D. Searle & Co. | Method of using (h+/k+) atpase inhibitors as antiviral agents |
DE19531148A1 (de) | 1995-08-24 | 1997-02-27 | Basf Ag | Fungizide Pyridin-2-yl-Derivate |
JP2002515023A (ja) | 1995-08-24 | 2002-05-21 | ビーエーエスエフ アクチェンゲゼルシャフト | N−複素環化合物、その製造用中間体、それを含む組成物及び有害菌類防除にそれを使用する方法 |
US6191280B1 (en) * | 1997-05-30 | 2001-02-20 | Basf Aktiengesellschaft | Method for producing substituted thiopyridines |
US6284923B1 (en) | 1997-08-22 | 2001-09-04 | Tularik Inc | Substituted benzene compounds as antiproliferative and cholesterol lowering action |
WO1999018096A1 (en) | 1997-10-02 | 1999-04-15 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6191170B1 (en) | 1998-01-13 | 2001-02-20 | Tularik Inc. | Benzenesulfonamides and benzamides as therapeutic agents |
SI0930302T1 (en) * | 1998-01-16 | 2003-10-31 | F. Hoffmann-La Roche Ag | Benzosulfone derivatives |
WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
AU2003211427A1 (en) | 2002-02-18 | 2003-09-04 | Ishihara Sangyo Kaisha, Ltd. | Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same |
US20030236287A1 (en) | 2002-05-03 | 2003-12-25 | Piotrowski David W. | Positive allosteric modulators of the nicotinic acetylcholine receptor |
US7037902B2 (en) | 2002-07-03 | 2006-05-02 | Receptron, Inc. | Affinity small molecules for the EPO receptor |
EP1651595A2 (en) | 2003-05-30 | 2006-05-03 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
EP1756084B1 (en) | 2004-06-04 | 2008-11-26 | Arena Pharmaceuticals, Inc. | Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
US20060019967A1 (en) * | 2004-07-21 | 2006-01-26 | Su-Ying Wu | SARS CoV main protease inhibitors |
GB0426313D0 (en) | 2004-12-01 | 2005-01-05 | Merck Sharp & Dohme | Therapeutic agents |
WO2006083692A2 (en) | 2005-01-28 | 2006-08-10 | Mount Sinai Schoool Of Medicine | Methods of identifying modulators of bromodomains |
GB0504828D0 (en) | 2005-03-09 | 2005-04-13 | Merck Sharp & Dohme | Therapeutic agents |
US20100048713A1 (en) | 2006-01-06 | 2010-02-25 | Aarhus Universitet | Compounds acting on the serotonin transporter |
JP2009535307A (ja) | 2006-04-28 | 2009-10-01 | アベキサ・リミテッド | インテグラーゼ阻害剤3 |
MX2010000617A (es) | 2007-07-17 | 2010-05-17 | Plexxikon Inc | Compuestos y metodos para modulacion de cinasa, e indicaciones de estos. |
CN101723932B (zh) | 2008-10-31 | 2013-11-20 | 北京以岭生物工程技术有限公司 | 硝基吡啶乙烯亚胺化合物、其药物组合物及其制备方法和用途 |
CA2763589A1 (en) | 2009-05-28 | 2010-12-02 | President And Fellows Of Harvard College | N,n'-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation |
KR101906146B1 (ko) | 2009-08-17 | 2018-10-10 | 메모리얼 슬로안-케터링 캔서 센터 | 열 충격 단백질 결합 화합물, 조성물, 및 이의 제조 방법 및 사용 방법 |
EP2535059A4 (en) | 2010-02-10 | 2014-03-12 | Public Univ Corp Yokohama City | USE OF A MSIN3B-BINDING COMPOUND WHICH BINDES SPECIFICLY TO THE SILENCER FACTOR OF NRSF NEURONIC SPECIFICATION |
CN102206172B (zh) | 2010-03-30 | 2015-02-25 | 中国医学科学院医药生物技术研究所 | 一组取代双芳基化合物及其制备方法和抗病毒应用 |
WO2012025638A1 (en) | 2010-08-27 | 2012-03-01 | Universität des Saarlandes | Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors |
WO2013119931A1 (en) | 2012-02-10 | 2013-08-15 | The Board Of Regents Of The University Of Texas System | Modulators of exchange proteins directly activated by camp (epacs) |
EP3019509B1 (en) | 2013-07-10 | 2019-09-11 | Boehringer Ingelheim International GmbH | Novel chiral nitrogen-phosphorus ligands and their use for asymmetric hydrogenation of alkenes |
CN104672214B (zh) | 2013-12-03 | 2019-04-12 | 上海翰森生物医药科技有限公司 | 具有alk抑制活性的化合物及其制备与用途 |
CN105503827B (zh) | 2014-10-11 | 2019-09-24 | 上海翰森生物医药科技有限公司 | Egfr抑制剂及其制备方法和用途 |
CN104987324B (zh) | 2015-06-04 | 2018-05-04 | 湖北生物医药产业技术研究院有限公司 | 作为alk抑制剂的嘧啶衍生物 |
CN105085483B (zh) | 2015-06-04 | 2019-01-01 | 湖北生物医药产业技术研究院有限公司 | 激酶抑制剂及其应用 |
GB201514021D0 (en) | 2015-08-07 | 2015-09-23 | Arner Elias Set Jeno | Novel Pyridines and their use in the treatment of cancer |
BR112019016223A2 (pt) | 2017-02-07 | 2020-04-07 | Oblique Therapeutics Ab | piridinas substituídas por heteroarilsulfonila e uso das mesmas no tratamento de câncer |
KR20190115012A (ko) | 2017-02-07 | 2019-10-10 | 오블리크 세러퓨틱스 에이비 | 헤테로사이클릴설포닐-치환된 피리딘 및 암의 치료에서 이의 용도 |
CN110382464A (zh) | 2017-02-07 | 2019-10-25 | 欧比力克治疗公司 | 烃基磺酰基取代的吡啶和其在癌症治疗中的用途 |
CA3051644A1 (en) | 2017-02-07 | 2018-08-16 | Oblique Therapeutics Ab | Sulfinylpyridines and their use in the treatment of cancer |
-
2015
- 2015-08-07 GB GBGB1514021.3A patent/GB201514021D0/en not_active Ceased
-
2016
- 2016-08-05 CA CA2995077A patent/CA2995077C/en active Active
- 2016-08-05 RU RU2018107879A patent/RU2730505C2/ru active
- 2016-08-05 KR KR1020187006536A patent/KR102180934B1/ko active IP Right Grant
- 2016-08-05 AU AU2016306276A patent/AU2016306276B2/en not_active Ceased
- 2016-08-05 CN CN201680046606.6A patent/CN108026044A/zh active Pending
- 2016-08-05 JP JP2018526611A patent/JP6636153B2/ja active Active
- 2016-08-05 MA MA042915A patent/MA42915A/fr unknown
- 2016-08-05 US US15/750,805 patent/US10899710B2/en active Active
- 2016-08-05 WO PCT/US2016/045731 patent/WO2017027359A1/en active Application Filing
- 2016-08-05 EP EP16759907.5A patent/EP3331858A1/en not_active Withdrawn
- 2016-08-05 MX MX2018001576A patent/MX2018001576A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2016306276A1 (en) | 2018-02-22 |
US10899710B2 (en) | 2021-01-26 |
WO2017027359A8 (en) | 2017-04-20 |
JP2018525443A (ja) | 2018-09-06 |
WO2017027359A1 (en) | 2017-02-16 |
RU2730505C2 (ru) | 2020-08-24 |
CA2995077A1 (en) | 2017-02-16 |
JP6636153B2 (ja) | 2020-01-29 |
MA42915A (fr) | 2018-08-01 |
GB201514021D0 (en) | 2015-09-23 |
CA2995077C (en) | 2020-04-21 |
KR102180934B1 (ko) | 2020-11-20 |
RU2018107879A (ru) | 2019-09-09 |
AU2016306276B2 (en) | 2019-08-01 |
RU2018107879A3 (es) | 2019-09-09 |
KR20180035904A (ko) | 2018-04-06 |
US20200087260A1 (en) | 2020-03-19 |
CN108026044A (zh) | 2018-05-11 |
EP3331858A1 (en) | 2018-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500987A1 (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
MX2018001576A (es) | Piridinas y su uso en el tratamiento del cancer. | |
PH12018501084A1 (en) | Heterocyclic compounds as immunomodulators | |
PH12018502710A1 (en) | Heterocyclic compounds as immunomodulators | |
PH12019501443A1 (en) | Benzooxazole derivatives as immunomodulators | |
MX2022002579A (es) | Compuestos de aminotiazol como inhibidores de c- kit. | |
MX2019009266A (es) | Piridinas sustituidas con hidrocarbilsulfonilo y su uso en el tratamiento del cancer. | |
MX2016006432A (es) | Tetrahidro-benzodiazepinonas. | |
PH12018502497A1 (en) | Adenosine derivatives for use in the treatment of cancer | |
PH12018502535A1 (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
MX2019009351A (es) | Piridinas sustituidas con heteroarilsulfonilo y su uso en el tratamiento del cancer. | |
MX2019009354A (es) | Piridinas sustituidas con heterociclilsulfonilo y su uso en el tratamiento del cancer. | |
TR201911244T4 (tr) | İmidazolonilkinolinler ve atm kinaz inhibitörleri olarak kullanımı. | |
MX2016002544A (es) | Compuestos utiles como inmunomoduladores. | |
MY198613A (en) | Nitrobenzyl derivatives of anti-cancer agents | |
MX2019009356A (es) | Sulfinilpiridinas y su uso en el tratamiento del cancer. | |
MX2015010128A (es) | Derivados de piridazinona macrociclicos. | |
MX2015010125A (es) | Derivados de piridazinona-amidas. | |
GEP20186933B (en) | Substituted dihydroisoquinoline compounds | |
MX2016009663A (es) | Derivados de icariina. | |
MX2018008362A (es) | Derivados de quinolin-2-ona. | |
PH12017501879A1 (en) | Methods for treating cancer | |
PH12017501071A1 (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
MY186475A (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. |